December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 26, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreDecember 26, 2025
The global cell and gene therapy GMP drug substance market was USD 0.74 billion in 2024 and is projected to reach USD 1.64 billion by 2034 at a CAGR of 8.2%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads, with Asia-Pacific growing fastest. The market features top players like AGC Bi...
December 26, 2025
The emerging need for oral medicines is due to the progression of diabetes, inadequate lifestyle management, and declining insulin production. North America dominated the market in 2024, driven by the growing aging population, innovative drug treatments, and improved access and affordability....
December 16, 2025
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 2026 to 2035....
December 12, 2025
The human insulin market is expanding steadily, rising from USD 20.97 billion in 2026 to USD 27.68 billion by 2035 at a CAGR of 3.13%, driven by increasing diabetes cases globally. This report covers complete segmentation by product, formulation, end user, application, and distribution channel, showing rapid-acting insulin holding a 50% share, whil...
December 12, 2025
The pharmacovigilance market is valued at USD 9.61 billion in 2026 and is projected to reach USD 16.87 billion by 2035, expanding at a CAGR of 6.45%.This market report covers detailed segmentation by service type with case processing leading at 31.3% in 2025, type outsourced segment commanding 72.4%, process flow (Phase IV holding 34.5%, and end us...
December 12, 2025
The anesthesia and muscle relaxants market is valued at USD 8.41 billion in 2026 and is projected to reach USD 12.65 billion by 2035, growing at a steady CAGR of 4.64%. This report covers a complete analysis of market segments drug types, route of administration, application, end users, and distribution channels....
November 28, 2025
Projections indicate that, birth control pills industry is projected to rise from USD 19.48 billion in 2025 to USD 30.63 billion by 2035, reflecting a CAGR of 4.63% over the next decade.The birth control pills market is expanding due to its growing innovations and approvals. North America led the market due to the growth in reproductive health awar...
November 28, 2025
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kidney disease, heart failure, and the use of RAAS inhibitors, increasing the need for effective potass...
November 27, 2025
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North America led the global market owing to a strong R&D pipeline & biopharmaceutical innovations in ...
November 24, 2025
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for pharmaceuticals rises amid chronic conditions & rare diseases. North America’s dominance c...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com